AstraZeneca to buy Ardea for $1.3 billion

AstraZeneca is to buy Ardea Biosciences for $1 billion to help bolster its pipeline. Under the terms of the agreement, AstraZeneca will acquire Ardea for $32 per share, which represents a total cash v…
Read the full story: InPharm